Paul W. Hoelscher - Net Worth and Insider Trading
Paul W. Hoelscher Net Worth
The estimated net worth of Paul W. Hoelscher is at least $16 Million dollars as of 2024-11-13. Paul W. Hoelscher is the EVP, CFO of Horizon Therapeutics PLC and owns about 140,511 shares of Horizon Therapeutics PLC (HZNP) stock worth over $16 Million. Details can be seen in Paul W. Hoelscher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul W. Hoelscher has not made any transactions after 2022-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul W. Hoelscher
Paul W. Hoelscher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul W. Hoelscher owns 2 companies in total, including Horizon Therapeutics PLC (HZNP) , and Reneo Pharmaceuticals Inc (RPHM) .
Click here to see the complete history of Paul W. Hoelscher’s form 4 insider trades.
Insider Ownership Summary of Paul W. Hoelscher
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HZNP | Horizon Therapeutics PLC | 2022-04-20 | EVP Finance |
RPHM | Reneo Pharmaceuticals Inc | 2022-01-20 | director |
Paul W. Hoelscher Latest Holdings Summary
Paul W. Hoelscher currently owns a total of 1 stock. Paul W. Hoelscher owns 140,511 shares of Horizon Therapeutics PLC (HZNP) as of April 20, 2022, with a value of $16 Million.
Latest Holdings of Paul W. Hoelscher
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HZNP | Horizon Therapeutics PLC | 2022-04-20 | 140,511 | 116.30 | 16,341,429 |
Holding Weightings of Paul W. Hoelscher
Paul W. Hoelscher Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul W. Hoelscher has made a total of 6 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 50,000 shares on April 20, 2022, which brought Paul W. Hoelscher around $6 Million.
Insider Trading History of Paul W. Hoelscher
- 1
Paul W. Hoelscher Trading Performance
Paul W. Hoelscher Ownership Network
Ownership Network List of Paul W. Hoelscher
Ownership Network Relation of Paul W. Hoelscher
Paul W. Hoelscher Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Paul W. Hoelscher is the EVP Finance of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Paul W. Hoelscher Mailing Address
Above is the net worth, insider trading, and ownership report for Paul W. Hoelscher. You might contact Paul W. Hoelscher via mailing address: 1 Horizon Way, C/o Horizon Therapeutics, Inc., Deerfield Il 60015.